Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera.

Han M, Nagele E, DeMarshall C, Acharya N, Nagele R.

PLoS One. 2012;7(2):e32383. doi: 10.1371/journal.pone.0032383. Epub 2012 Feb 22.

2.

Biomarkers in Parkinson's disease.

Morgan JC, Mehta SH, Sethi KD.

Curr Neurol Neurosci Rep. 2010 Nov;10(6):423-30. doi: 10.1007/s11910-010-0144-0. Review.

PMID:
20809400
3.

Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Noelker C, Hampel H, Dodel R.

Mol Diagn Ther. 2011 Apr 1;15(2):83-102. doi: 10.2165/11534870-000000000-00000. Review.

PMID:
21623645
4.

Biomarkers for the early detection of Parkinson's and Alzheimer's disease.

Berg D.

Neurodegener Dis. 2008;5(3-4):133-6. doi: 10.1159/000113682. Epub 2008 Mar 6. Review.

PMID:
18322370
5.

Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.

Dupiereux I, Zorzi W, Quadrio I, Perret-Liaudet A, Kovacs GG, Heinen E, Elmoualij B.

Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):2-11. Review.

PMID:
20021333
6.

Biomarkers for the diagnosis and management of Parkinson's disease.

Waragai M, Sekiyama K, Fujita M, Tokuda T, Hashimoto M.

Expert Opin Med Diagn. 2013 Jan;7(1):71-83. doi: 10.1517/17530059.2013.733694. Epub 2012 Nov 4. Review.

PMID:
23530844
7.

Improving outcomes through early diagnosis of Parkinson's disease.

Pagan FL.

Am J Manag Care. 2012 Sep;18(7 Suppl):S176-82. Review.

8.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14. Review.

PMID:
27046268
9.

Biomarkers of neurodegenerative disorders: how good are they?

Rachakonda V, Pan TH, LE WD.

Cell Res. 2004 Oct;14(5):347-58. Review.

10.

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression.

Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E.

Autoimmun Rev. 2010 Oct;9(12):807-11. doi: 10.1016/j.autrev.2010.07.008. Epub 2010 Jul 23. Review. Erratum in: Autoimmun Rev. 2012 Mar;11(5):374.

PMID:
20656067
11.

Serum autoantibodies as biomarkers for early cancer detection.

Tan HT, Low J, Lim SG, Chung MC.

FEBS J. 2009 Dec;276(23):6880-904. doi: 10.1111/j.1742-4658.2009.07396.x. Epub 2009 Oct 26. Review.

12.

New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.

Meuwis MA, Fillet M, Chapelle JP, Malaise M, Louis E, Merville MP.

Expert Rev Mol Diagn. 2008 May;8(3):327-37. doi: 10.1586/14737159.8.3.327. Review.

PMID:
18598111
13.

miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.

Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA.

Med Chem. 2016;12(3):217-25. Review.

PMID:
26527155
14.

Biomarkers of Alzheimer's disease in body fluids.

Zheng Y, He J, Hong T.

Sci China Life Sci. 2010 Apr;53(4):490-6. doi: 10.1007/s11427-010-0081-9. Epub 2010 May 7. Review.

PMID:
20596916
15.

The search for biomarkers in Parkinson's disease: a critical review.

Antoniades CA, Barker RA.

Expert Rev Neurother. 2008 Dec;8(12):1841-52. doi: 10.1586/14737175.8.12.1841. Review.

PMID:
19086880
16.

Biomarkers in Parkinson's disease.

Dorsey ER, Holloway RG, Ravina BM.

Expert Rev Neurother. 2006 Jun;6(6):823-31. Review.

PMID:
16784406
17.

Biomarkers of Parkinson's disease and Dementia with Lewy bodies.

Henchcliffe C, Dodel R, Beal MF.

Prog Neurobiol. 2011 Dec;95(4):601-13. doi: 10.1016/j.pneurobio.2011.09.002. Epub 2011 Sep 19. Review.

PMID:
21983334
18.

Development of Parkinson's disease biomarkers.

Prakash KM, Tan EK.

Expert Rev Neurother. 2010 Dec;10(12):1811-25. doi: 10.1586/ern.10.73. Review.

PMID:
21091313
19.

An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.

Batistela MS, Josviak ND, Sulzbach CD, de Souza RL.

Int J Neurosci. 2017 Jun;127(6):547-558. doi: 10.1080/00207454.2016.1209754. Epub 2016 Jul 20. Review.

PMID:
27381850
20.

Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation.

Alberio T, Bucci EM, Natale M, Bonino D, Di Giovanni M, Bottacchi E, Fasano M.

J Proteomics. 2013 Sep 2;90:107-14. doi: 10.1016/j.jprot.2013.01.025. Epub 2013 Feb 4. Review.

PMID:
23385359

Supplemental Content

Support Center